Putative Neuroprotective Agents in Neuropsychiatric Disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry - Netherlands
doi 10.1016/j.pnpbp.2012.11.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Viruses and Neuropsychiatric Disorders

Journal of the Royal Society of Medicine
Medicine
1988English

Epigenetic Regulations in Neuropsychiatric Disorders

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

GABA and Neuropsychiatric Disorders

Canadian Journal of Neurological Sciences
MedicineNeurology
1980English

Carboxyfullerenes as Neuroprotective Agents

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

Early Origins of Neuropsychiatric Disorders

Pediatric Research
Child HealthPediatricsPerinatology
2018English

Diagnostic Value of Salivary Markers in Neuropsychiatric Disorders

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Unravelling Basic Mechanisms in Addiction and Neuropsychiatric Disorders

European Archives of Psychiatry and Clinical Neuroscience
MedicinePsychiatryMental HealthBiological PsychiatryPharmacology
2015English

Fragile X-Associated Neuropsychiatric Disorders (FXAND)

Frontiers in Psychiatry
PsychiatryMental Health
2018English

Autoimmune Neuropsychiatric Disorders Associated With Infection

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy